Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia - Poll - MDSpire

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

  • By

  • Ya Wang

  • Tiantian Yu

  • Ming Wang

  • Li Yu

  • July 15, 2026

Share

Original Source(s)

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

  • by Ya Wang, Tiantian Yu, Ming Wang, Li Yu

  • July 15, 2026

Related Content

Prognostic significance of extracapsular extension in patients with non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a retrospective cohort study

Editorial: Molecular pathways and signaling molecules in cancer therapy: advances and innovations

GLA is associated with ESCC progression and chemotherapy response via DNA damage repair–related pathways